Citation Impact
Citing Papers
Effects of Continuous Versus Cyclical Oral Contraception: A Randomized Controlled Trial
2007
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults
2002
Erectile Dysfunction and Hypogonadism among Men with HIV
2007
Direct Evidence that Saquinavir Is Transported by Multidrug Resistance-Associated Protein (MRP1) and Canalicular Multispecific Organic Anion Transporter (MRP2)
2002
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
2006
Atp Binding Cassette Multidrug Transporters Limit the Anti-HIV Activity of Zidovudine and Indinavir in Infected Human Macrophages
2004
The metabolism of 16-fluoroestradiols in vivo: Chemical strategies for restricting the oxidative biotransformations of an estrogen-receptor imaging agent
1997
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
P450 Enzymes
1992
Effects of Fluorine Substitution on Drug Metabolism: Pharmacological and Toxicological Implications
1994
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
The Pharmacogenetics of Immunosuppression for Organ Transplantation
2003
Emerging organic contaminants in groundwater: A review of sources, fate and occurrence
2012 Standout
Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
2002 Standout
Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication
1995
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Severe and complicated malaria
1990 Standout
Structure and function of the blood–brain barrier
2009 Standout
Current role of LC-MS in therapeutic drug monitoring
2007
Oral Anticoagulant Therapy
2012 Standout
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy
2010
Drug-Induced Hepatotoxicity
2003 Standout
Clomethiazole (Zendra®) in Acute Ischemic Stroke Basic Pharmacology and Biochemistry and Clinical Efficacy
1998
Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration Policy
1993
Chemo-enzymatic fluorination of unactivated organic compounds
2008 StandoutNobel
What Makes Clinical Research Ethical?
2000 Standout
Toxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase
2001
RECENT DEVELOPMENTS IN ANTIFUNGAL THERAPY
1996
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Comparative Pharmacology of Newer Progestogens
1996
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Drug–Grapefruit Juice Interactions
2000
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Targeting multidrug resistance in cancer
2006 Standout
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
2008
Clinical Pharmacokinetics and Summary of Efficacy and Tolerability of Atazanavir
2005
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385
2006
Chimeric mice with humanized liver
2007
Lopinavir/Ritonavir
2003
Polycystic Ovary Syndrome
2005 Standout
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
1998
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Functional Genomic Analysis of C. elegans Molting
2005 StandoutNobel
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability
2003
Antifungal agents: An overview. Part II
1994
Pharmacology of estrogens and progestogens: influence of different routes of administration
2005
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
2009
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Emptying of intracellular Ca2+ stores releases a novel small messenger that stimulates Ca2+ influx
1993 StandoutNatureNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Fluconazole
1995
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
A Mechanistic Approach to Antiepileptic Drug Interactions
1998
Copper-Mediated Coupling Reactions and Their Applications in Natural Products and Designed Biomolecules Synthesis
2008 Standout
Fluorine in medicinal chemistry
2007 Standout
Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads
2003
Drug−Protein Adducts: An Industry Perspective on Minimizing the Potential for Drug Bioactivation in Drug Discovery and Development
2003
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Graphitic carbon nitride based nanocomposites: a review
2014 Standout
Cytochrome P450 may regulate plasma membrane Ca 2+ permeability according to the filling state of the intracellular Ca 2+ stores
1992
Current and Emerging Azole Antifungal Agents
1999 Standout
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
1997
The Many Roles for Fluorine in Medicinal Chemistry
2008 Standout
Some observations on molecular weight estimations by molecular-sieve chromatography
1966 StandoutNobel
Guidelines for the Primary Prevention of Stroke
2014 Standout
Behaviors of Glucocorticoids, Androgens and Progestogens in a Municipal Sewage Treatment Plant: Comparison to Estrogens
2011
Impact of Highly Active Antiretroviral Treatment on HIV Seroincidence Among Men Who Have Sex With Men: San Francisco
2002
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Medroxyprogesterone Acetate and Dexamethasone Are Competitive Inhibitors of Different Human Steroidogenic Enzymes1
1999
Metabolism of Fluorine-Containing Drugs
2001
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Systemic Antifungal Agents
1998
Insecticide-treated bed nets and curtains for preventing malaria
2004 Standout
Occurrence and Fate of Estrone, 17β-estradiol and 17α-ethynylestradiol in STPs for Domestic Wastewater
2005
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
2006 Standout
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy
2002 Standout
Towards a small animal model for hepatitis C
2009 StandoutNobel
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Some recently developed fractionation procedures and their application to peptide and protein hormones
1963
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Works of D.J. Back being referenced
Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport
2001
Azoles, a48 llylamines and drug metabolism
1992
Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6β-hydroxycortisol
1993
Metabolism of the contraceptive steroid desogestrel by human liver in vitro
1990
Cortisol metabolism by human liver in vitro—IV. Metabolism of 9α-fluorocortisol by human liver microsomes and cytosol
1993
Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals
2005
Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide
1988
Intracellular Activation of 2',3'-Dideoxyinosine and Drug Interactions in Vitro
1999
In vitro metabolism of dexamethasone (DEX) in human liver and kidney: The involvement of CYP3a4 and CYP17 (17,20 LYASE) and molecular modelling studies
1997
The lack of interaction between temafloxacin and combined oral contraceptive steroids
1991
Dexamethasone metabolism in vitro: Species differences
1997
Interaction of sildenafil and indinavir when co-administered to HIV-positive patients
1999
Principles and practice of HIV‐protease inhibitor pharmacoenhancement
2001
Comparative pharmacokinetics of levonqrgestrel and ethinyloestradiol following intravenous, oral and vaginal administration
1987
An antibiotic interaction with ethinyloestradiol in the rat and rabbit
1982
The effect of rifampicin on norethisterone pharmacokinetics
1979
Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure‐activity relationship
1985
The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids
1986
The effect of cotrimoxazole on oral contraceptive steroids in women
1983
An investigation of the pharmacokinetics of ethynylestsadiol in women using badioimmunoassay
1979
Plasma and whole blood mefloquine concentrations during treatment of chloroquine‐resistant falciparum malaria with the combination mefloquine‐sulphadoxine‐pyrimethamine.
1987
Effect of chlormethiazole on hepatic monooxygenases activity in vivo
1993
Interindividual Variation and Drug Interactions with Hormonal Steroid Contraceptives
1981
Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel
1987
The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects
1987
Intestinal metabolism of ethinyloestradiol and paracetamol in vitro: studies using Ussing chambers.
1987
Urinary concentrations of steroid glucuronides in women taking oral contraceptives
1983